AFFORDABLE MEDICINES TO TREAT SKIN CANCER, LUNG CANCER AND XLH
October 22, 2022
From 1 November 2022, Australians will have access to new and updated medicines under the Pharmaceutical Benefits Scheme (PBS). These include listings for skin cancer, lung cancer and genetic disease X-linked hypophosphataemia (XLH).
Read More